Oncotype DX Stories

Karen K.

Karen was a borderline case for chemotherapy.

Her Oncotype DX Recurrence Score result indicated that she was unlikely to benefit from chemotherapy.

Karen, originally from the Orkney Islands in Scotland but now living in the UK's beautiful Lake District, was diagnosed with invasive breast cancer in November 2010 following a routine mammogram at her local hospital. She underwent surgery and six weeks of radiotherapy, but was unsure whether to opt for subsequent chemotherapy after witnessing the harsh side effects it can have, "My sister had chemo and suffered terribly. If I had needed chemo I would have had it, but didn't want to put myself through it unnecessarily," she said at the time.

“My sister had chemo and suffered terribly. If I had needed chemo I would have had it, but didn't want to put myself through it unnecessarily.”

Karen was a borderline case for chemotherapy and her consultant told her about the Oncotype DX test. Karen discussed her options at length with her husband and family, and decided to go ahead with the genomic testing of her tumor. Her Oncotype DX Recurrence Score result indicated that she was unlikely to benefit from chemotherapy.

Recently retired from her high profile job in the Civil Service, football fan Karen seeks sanctuary in her garden, although doesn't always enjoy the maintenance that goes with it! She has travelled extensively in the UK in a VW camper van with her husband of 42 years, has two children - Mara and Paul - and three grown up grandchildren. Other important members of the family include two very pampered cats.

Back to Search Results

Patient
Profile

Name: Karen K.
Age: 63
Year Diagnosed: 2010
Recurrence Score: Intermediate

Submit
Your Story

Tell us about your experience with Oncotype DX